Successfully creating a new pain medication without the addictive properties linked to opioids will require innovative research models, a public health professor told Bloomberg Law.
“The development of non-addictive painkillers has been a holy grail for decades, and there are no obvious candidates in the pipeline,” Margaret “Mimi” Foster Riley said. “That may require us to develop partnerships and refocus research dollars in a way that we have not done before—perhaps similar to some of our initiatives to fight cancer.” Foster Riley, who teaches food and drug law as well as the regulation of clinical research at the University of ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.